<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotech License &#187; Biotech Licensing</title>
	<atom:link href="http://biotechlicense.com/biotech-licensing/feed/" rel="self" type="application/rss+xml" />
	<link>http://biotechlicense.com</link>
	<description>Developments from the world of Biotechnology</description>
	<lastBuildDate>Thu, 29 Jul 2010 20:18:41 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>ibuprofen oral suspension</title>
		<link>http://pharmalicensing.com/licensing/displicopp/5101</link>
		<comments>http://pharmalicensing.com/licensing/displicopp/5101#comments</comments>
		<pubDate>Thu, 29 Jul 2010 20:18:41 +0000</pubDate>
		<dc:creator>Pharmalicensing.com</dc:creator>
				<category><![CDATA[Biotech Licensing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[licensing]]></category>

		<guid isPermaLink="false">http://pharmalicensing.com/licensing/displicopp/5101</guid>
		<description><![CDATA[Need to in-license Ibuprofen Oral suspension for UK]]></description>
			<content:encoded><![CDATA[Need to in-license Ibuprofen Oral suspension for UK]]></content:encoded>
			<wfw:commentRss>http://pharmalicensing.com/licensing/displicopp/5101/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ErbB peptides for treating cancer</title>
		<link>http://pharmalicensing.com/licensing/displicopp/18627</link>
		<comments>http://pharmalicensing.com/licensing/displicopp/18627#comments</comments>
		<pubDate>Wed, 28 Jul 2010 20:13:02 +0000</pubDate>
		<dc:creator>Pharmalicensing.com</dc:creator>
				<category><![CDATA[Biotech Licensing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[licensing]]></category>

		<guid isPermaLink="false">http://pharmalicensing.com/licensing/displicopp/18627</guid>
		<description><![CDATA[Novel peptides for treating a large variety of cancers.  The erbB receptor family is expressed in a variety of different human tumors including breast, head and neck, gastric, colorectal, prostate, bladder, renal, pancreatic, and ovarian. In some...]]></description>
			<content:encoded><![CDATA[Novel peptides for treating a large variety of cancers.  The erbB receptor family is expressed in a variety of different human tumors including breast, head and neck, gastric, colorectal, prostate, bladder, renal, pancreatic, and ovarian. In some...]]></content:encoded>
			<wfw:commentRss>http://pharmalicensing.com/licensing/displicopp/18627/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bovine TB test kit</title>
		<link>http://pharmalicensing.com/licensing/displicopp/18676</link>
		<comments>http://pharmalicensing.com/licensing/displicopp/18676#comments</comments>
		<pubDate>Sun, 25 Jul 2010 19:49:38 +0000</pubDate>
		<dc:creator>Pharmalicensing.com</dc:creator>
				<category><![CDATA[Biotech Licensing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[licensing]]></category>

		<guid isPermaLink="false">http://pharmalicensing.com/licensing/displicopp/18676</guid>
		<description><![CDATA[Fluid-based bio-optical sensor and portable reader]]></description>
			<content:encoded><![CDATA[Fluid-based bio-optical sensor and portable reader]]></content:encoded>
			<wfw:commentRss>http://pharmalicensing.com/licensing/displicopp/18676/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia</title>
		<link>http://pharmalicensing.com/licensing/displicopp/7771</link>
		<comments>http://pharmalicensing.com/licensing/displicopp/7771#comments</comments>
		<pubDate>Sat, 24 Jul 2010 19:27:28 +0000</pubDate>
		<dc:creator>Pharmalicensing.com</dc:creator>
				<category><![CDATA[Biotech Licensing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[licensing]]></category>

		<guid isPermaLink="false">http://pharmalicensing.com/licensing/displicopp/7771</guid>
		<description><![CDATA[Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia]]></description>
			<content:encoded><![CDATA[Methods and Compositions for Promoting Hair Growth: Treatment of Male and Female Androgenic Alopecia]]></content:encoded>
			<wfw:commentRss>http://pharmalicensing.com/licensing/displicopp/7771/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Loratadine orally disintegrating tablets 5mg and 10mg</title>
		<link>http://pharmalicensing.com/licensing/displicopp/18637</link>
		<comments>http://pharmalicensing.com/licensing/displicopp/18637#comments</comments>
		<pubDate>Fri, 23 Jul 2010 19:26:22 +0000</pubDate>
		<dc:creator>Pharmalicensing.com</dc:creator>
				<category><![CDATA[Biotech Licensing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotechnology]]></category>
		<category><![CDATA[licensing]]></category>

		<guid isPermaLink="false">http://pharmalicensing.com/licensing/displicopp/18637</guid>
		<description><![CDATA[Rubicon has developed a generic equivalent, pleasant tasting, robust, stable orally disintegrating tablets of Loratadine which can be packed in unit dose blister packs and offers product launching opportunity in regulated and semi or non regulated market.]]></description>
			<content:encoded><![CDATA[Rubicon has developed a generic equivalent, pleasant tasting, robust, stable orally disintegrating tablets of Loratadine which can be packed in unit dose blister packs and offers product launching opportunity in regulated and semi or non regulated market.]]></content:encoded>
			<wfw:commentRss>http://pharmalicensing.com/licensing/displicopp/18637/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
